Combination treatment with interferon (IFN) and ribavirin (RBV) for hepatitis C (HCV) in HIV co-infection patients.

被引：0
|
作者：
Dieterich, DT
Weisz, KB
Goldman, DJ
Malicdem, ML
机构：
[1] Cabrini Med Ctr, New York, NY USA
[2] Liberty Med LLP, New York, NY USA
来源：
HEPATOLOGY | 1999年 / 30卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
422
引用
下载
收藏
页码：266A / 266A
页数：1
相关论文
共 50 条
  • [1] Treatment of hepatitis C (HCV) infection in patients with bleeding disorders using an interferon (IFN)/ribavirin (RBV) combination.
    Shields, PL
    Mutimer, DJ
    Roberts, A
    Britnell, T
    Wilde, JT
    BRITISH JOURNAL OF HAEMATOLOGY, 1998, 101 : 84 - 84
  • [2] Treatment of hepatitis C (HCV) infection in patients with bleeding disorders using an interferon (IFN) ribavirin (RBV) combination.
    Shields, PL
    Mutimer, DJ
    Roberts, A
    Britnell, T
    Wilde, JT
    GUT, 1998, 42 : A21 - A21
  • [3] HCV treatment with pegylated interferon and ribavirin in patients with haemophilia and HIV/HCV co-infection
    Denholm, J. T.
    Wright, E. J.
    Street, A.
    Sasadeusz, J. J.
    HAEMOPHILIA, 2009, 15 (02) : 538 - 543
  • [4] Low dose ribavirin (RBV) in combination interferon (IFN) for the treatment of hepatitis C non-responder and relapse patients.
    Bernstein, DE
    Khan, R
    Jeffers, LJ
    Reddy, KR
    Schiff, ER
    HEPATOLOGY, 1998, 28 (04) : 702A - 702A
  • [5] TREATMENT WITH INTERFERON (IFN) PLUS RIBAVIRIN (RBV) OF β-THALASSEMIC PATIENTS WITH HCV CHRONIC HEPATITIS
    DeSantis, A.
    Cristofari, F.
    Giubilo, F.
    Bassanelli, C.
    Losardo, A. A.
    Pugliese, P.
    Iegri, C.
    Gigliotti, F.
    Attili, A. F.
    DIGESTIVE AND LIVER DISEASE, 2010, 42 : S46 - S46
  • [6] Effect of the treatment of hepatitis C with interferon (IFN) and ribavirin (RBV) in body composition measurement by DEXA in HIV-HCV infected patients
    De Los Santos, I
    Sanz, J.
    Manzano Luque, M.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2012, 15 : 43 - 43
  • [7] Human immune deficiency virus (HIV) co-infection impairs responsiveness to interferon (IFN) and ribavirin (RBV) combination in patients with chronic hepatitis C: Preliminary results of a comparative study.
    Puoti, M
    Barbara, Z
    Paolo, Q
    Santantonio, T
    Cavaliere, R
    Castelli, F
    Serena, Z
    Roldan, EQ
    Suter, F
    Pastore, G
    Carosi, G
    HEPATOLOGY, 2002, 36 (04) : 289A - 289A
  • [8] Combination treatment with interferon (IFN) and ribavirin (RBV) in HCV (+)HIV(-) haemophilia pts, non responders (NR) to IFN monotherapy
    Katsarou, O
    Gialeraki, A
    Loukopoulou, H
    Hatzakis, A
    Karafoulidou, A
    JOURNAL OF HEPATOLOGY, 2000, 32 : 189 - 189
  • [9] Interferon and ribavirin combination therapy clears HCV in hepatitis B and C co-infection patients as effectively as in simple hepatitis C: A pilot study
    Chen, PJ
    Liu, CJ
    Kao, JH
    Lai, MY
    Chen, DS
    JOURNAL OF HEPATOLOGY, 2002, 36 : 174 - 174
  • [10] Assessing the contribution of treatment duration to rate of response in patients with chronic hepatitis C (HCV) infection receiving combined interferon (IFN) and ribavirin (RBV)
    Sette, H
    Pessoa, MG
    Barros, MA
    Cury, RA
    Marujo, W
    Terrault, NA
    HEPATOLOGY, 1998, 28 (04) : 575A - 575A
12345